openPR Logo
Press release

Dextra UK Launched the World's Largest Commercial Glycan Array

08-31-2016 12:43 PM CET | Science & Education

Press release from: MoBiTec GmbH

Dextra UK Launched the World's Largest Commercial Glycan Array

Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries.

Dextra and the Institute for Glycomics at Griffith University have partnered to launch the world's largest commercial glycan array and bioanalytical offering. The array features over 100 unique glycans, selected from a highly diverse library of glycan structures printed onto an epoxy coated slide.

This array enables rapid, high-throughput detection of the glycan interactions across a wide range of samples from proteins to whole cells, making it an extremely powerful tool in the study of the molecular biology of disease. The product manual provides more detailed information regarding the usage of the Glycan Array (Product Code: GAK001).

Product description:

1. Amine-functionalized glycans are printed onto epoxy-coated microarray slides through the use of a microarray printer.

2. Samples which can be used on the glycan array slide range from proteins to whole cells. Samples are fluorescently labeled for detection, either by fluorescent conjugate antibodies, or by directly labeling the sample with a fluorescent dye.

3. Slide images are acquired using a microarray scanner with appropriate settings for the fluorophore used. Analysis of images is performed using microarray analysis software and supplied gal. file for alignment.

Glycan Array includes:

1 x Dextra Glycan Array slide with barcode
3 x Blue Gene Frames with coverslips (volume of 65 μL).
Each slide contains three identical subarrays, with six spot replicates printed per array

Glycan strucures used for Glycan Array:

· Sialylated oligosaccharides

· Oligomannose core structures

· Lactose based O-glycans

· Galα1-3Gal series

· Cell adhesion molecules

· Blood group and Lewis antigens

· N-Acetyllactosamine and Analogues

· Complex type N-glycans

· Sialylated oligosaccharides

· Heparin and chondriotin derived oligosaccharides

· N-Acetylgalactosamine core structures

· Maltooligosaccharides

· Neutral and sulfated Galacto-oligosaccharides

For further details and ordering information please see:
http://www.mobitec.com/cms/products/bio/08_glycobio/glycan-array-kit.html

About MoBiTec GmbH

MoBiTec GmbH (Goettingen, Germany) is a privately held company, founded in 1987, that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.

In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.

MoBiTec GmbH
Arne Schulz
Lotzestr. 22a
37083 Goettingen, Germany

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dextra UK Launched the World's Largest Commercial Glycan Array here

News-ID: 359650 • Views:

More Releases from MoBiTec GmbH

FerroFarRed - An Ion Indicator for the Specific Detection of Fe2+
FerroFarRed - An Ion Indicator for the Specific Detection of Fe2+
Intracellular Fe2+ can react with hydrogen peroxide, thereby producing the hydroxyl radical, a reactive oxygen species (ROS). Excessive ROS causes oxidative stress, resulting in cancer and neurodegenerative diseases. FerroFarRed (also known as SiRhoNox-1 or ER-SiRhoNox) is a fluorescent probe,manufactured by Goryo Chemical, Japan, distributed in Europe by MoBiTec GmbH, Germany. FerroFarRed specifically detects labile iron (II) ions (Fe2+) and is known to react with Fe2+ only, separately from other metal
TransIT-VirusGEN® Transfection Reagent - Ideal for Recombinant Adeno-associated Virus Production
TransIT-VirusGEN® Transfection Reagent - Ideal for Recombinant Adeno-associated …
TransIT-VirusGEN® Transfection Reagent by Mirus, USA, is designed to enhance delivery of packaging and transfer vectors to adherent and suspension HEK 293 cell types to increase recombinant adeno-associated virus (AAV) and lentivirus production. Adeno-associated virus (AAV) is a nonenveloped, single stranded DNA virus from the Paroviridae family notable for its lack of pathogenicity, low immunogenicity and ability to infect both dividing and quiescent cells. Because AAV is replication-defective in the
Elabscience's Vast Portfolio of Products for Life Science Research Distributed by MoBiTec Germany
Elabscience's Vast Portfolio of Products for Life Science Research Distributed b …
MoBiTec's most recent select partner Elabscience specializes in immunodiagnostic technology for the life science community, offering a complete platform for R&D and manufacture. Elabscience major products cover Proteins, Antibodies, ELlSA Kits, CLIA Kits, Labeling Kits,Biochemical Kits, Cell Lines, and Other Reagents. Elabscience also offers custom services for customers, including Protein Expression and Purification Service, Custom Antibody Service, Custom ELISA Service, Cell Biology Service, Molecular Biology Service, and Whole Research Project Solutions. Every
MoBiTec to Exhibit at Potsdam Days on Bioanalysis 2018, Taking Place in Potsdam, Germany
MoBiTec to Exhibit at Potsdam Days on Bioanalysis 2018, Taking Place in Potsdam, …
The "Potsdam Days on Bioanalysis" provide an excellent platform for researchers, clinicians, and entrepreneurs to discuss diagnostics' hot topics, trends, and recent developments as well as new areas of application and future markets. Often, the implementation of goal-oriented and profitable cooperations is quite a challenge, in particular when it comes to innovative product developments in the fields of diagnostics and analytics. Typically, challenges lie within finding the right cooperation partners, identifying

All 5 Releases


More Releases for Glycan

The Glycan Analysis Market To Strive With Vertical Saas
Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product can
Glycan Analysis Market To Keep Up The Innovative Spirit
The Glycan Analysis Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. Therapeutic monoclonal
Global and Japan Glycan Sequencing Market 2021 | Detailed Report
Glycan Sequencing Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Glycan Sequencing Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5044460 The report provides a comprehensive analysis of company profiles listed below: - Merck & Co Inc - Charles River -
Glycan Sequencing Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Glycan Sequencing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Glycan Sequencing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Glycan Sequencing with respect to individual growth
Global Glycan Analysis Market Made Impressive Gains By 2025
Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product
Glycan Analysis Market Snapshot by 2017 – 2025
Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product